<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repositorio.ufc.br/handle/riufc/56326">
    <title>DSpace Coleção:</title>
    <link>http://repositorio.ufc.br/handle/riufc/56326</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/85535" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/83037" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/82432" />
        <rdf:li rdf:resource="http://repositorio.ufc.br/handle/riufc/78414" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-13T20:05:13Z</dc:date>
  </channel>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/85535">
    <title>Perfil clínico-epidemiológico das infecções causadas por Trichosporon spp. em um hospital pediátrico de referência e busca de novas estratégias de controle do crescimento fúngico</title>
    <link>http://repositorio.ufc.br/handle/riufc/85535</link>
    <description>Título: Perfil clínico-epidemiológico das infecções causadas por Trichosporon spp. em um hospital pediátrico de referência e busca de novas estratégias de controle do crescimento fúngico
Autor(es): Silva, Bruno Nascimento da
Abstract: Invasive fungal infections (IFIs) involve contamination of the bloodstream and invasion of sterile tissues and/or organs and are considered highly relevant public health issues due to high morbidity and mortality rates. Trichosporon spp. are considered opportunistic fungi, as they take advantage of microbial dysbiosis and host immune imbalance to cause serious invasive infections. This study investigated the clinical and epidemiological profile of invasive infections by Trichosporon spp., as well as the impact of calcineurin and Hsp90 protein inhibition on the growth of this pathogen. The epidemiological study included 28 isolates of interest. Data from these patients were collected and analyzed regarding: age, sex, most prevalent species of the genus, distribution by hospital unit, reasons for care, use of invasive devices, clinical specimens from which pathogens were isolated, use of antimicrobials and other conditioning drugs, co-infection, and treatment measures – all of which were associated with the clinical outcome (discharge or death). The strains isolated and selected in the prospective phase (n=12) were studied for their ability to form biofilms and their sensitivity profile to amphotericin B (AMB), voriconazole (VRZ), and fluconazole (FLZ). The second phase of the work concerns the inhibition of calcineurin by the use of Cyclosporine A (CsA), against planktonic cells and biofilms of Trichosporon spp. strains in n=13 already contained in stock. These biofilms were formed in the presence of CsA at concentrations of 25 µg/mL, 50 µg/mL, and 100 µg/mL for the planktonic state and 50 µg/mL and 100 µg/mL for the biofilms. Subsequently, CsA at the same concentrations mentioned above were associated with the antifungals AMB (10 µg/mL), VRZ (50 µg/mL), and FLZ (64 µg/mL) and subjected to the same tests. The impact of CsA on the ultrastructure of the biofilms was evaluated by Scanning Electron Microscopy (SEM) both in isolation and in combination with the antifungals. Bioinformatics analyses were performed to investigate the antibiofilm potential caused by calcineurin inhibition in T. asahii. In the inhibition of Hsp90 using Radicicol (RAD), the strains were subjected to planktonic sensitivity testing and subsequently studied with mature biofilms (48h) exposed to RAD at concentrations of 6.25 µg/mL for T. asahii and 10 µg/mL for T. inkin. Then, the same concentrations of RAD in the mature biofilms were associated with AMB 4 µg/mL for T. asahii and 2 µg/mL for T. inkin and VRZ 0.125 µg/mL for an additional 24h in contact with the mature biofilm in vitro, the morphology of the biofilms was assessed by SEM, and virulence was evaluated using an experimental infection model with Galleria mellonella larvae. The epidemiological study showed that the most affected pediatric population over the years were boys, most of whom were admitted to Intensive Care Units (ICUs). Patients with neurological diseases and cancer; those using various invasive medical devices, such as feeding tubes; most samples isolated from urine; a significant portion used prophylactic antimicrobials; mortality rates are considerable; the most prevalent species is T. asahii; the strains obtained are capable of forming biofilms. CsA and RAD, isolated and in combination with antifungals, are able to inhibit the fungal growth of T. inkin and T. asahii in vitro and significantly alter the ultrastructure of biofilms. RAD is effective in treating infected G. mellonella larvae. These results suggest new and promising therapeutic targets for invasive trichosporonosis, considering the difficulty and resistance in treating these infections
Tipo: Tese</description>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/83037">
    <title>Análise do perfil sorológico, clínico, sociodemográfico e da influência dos polimorfismos -174 G/C (rs1800795) do gene IL-6 e -308 G/A (rs1800629) do gene TNFα em pacientes acometidos por febre Chikungunya no estado do Ceará</title>
    <link>http://repositorio.ufc.br/handle/riufc/83037</link>
    <description>Título: Análise do perfil sorológico, clínico, sociodemográfico e da influência dos polimorfismos -174 G/C (rs1800795) do gene IL-6 e -308 G/A (rs1800629) do gene TNFα em pacientes acometidos por febre Chikungunya no estado do Ceará
Autor(es): Maciel, Mariella Sousa Coêlho
Abstract: The chikungunya fever (CHIKF) is a viral disease of acute onset, characterized by cause arthralgia involving one or more joints. The disease is caused by infection with Chikungunya virus (CHIKV) and affects thousands of people annually. Some affected individuals persist with joint symptoms for months or years, giving rise to the chronic phase of the disease. Factors inherent to both the microorganism and the host may be involved in susceptibility, progression or protection against CHIKF. Among the host factors, stand out the type of immune response and genetic factors, such as single nucleotide genetic polymorphisms (SNPs) in cytokine genes. The present study aimed to analyze the sociodemographic and serological profile, the prevalence and influence of SNPs -174 G/C (rs1800795) of the IL-6 gene and -308 G/A (rs1800629) of the TNFα gene in control patients and affected individuals by CHIKF in the state of Ceará. Serological ELISA tests and DNA extraction were performed. All samples were genotyped using the real-time PCR technique for variants in the IL-6 and TNFα genes. Statistical analyzes were performed using the Bioestat 5.0 software and included Fisher's Exact Test and Chi-square (x²), considering p &lt; 0.05 as the level of statistical significance. A total of 313 subjects composed the study, of which 102 were allocated to the positive cases (PC) group, 182 to the negative control (NC) group and 29 were asymptomatic (ASY). The arthralgia was present in 100% of the cases in the PC group, statistically significant differences (p &lt; 0.05) were evidenced for joint pain intensities between male and female genders. A higher frequency of the G/A genotype of the SNP -308 G/A in the TNFα gene was observed in the PC group in relation to the NC, as well as a higher frequency of the A allele. The mutant allele A was also identified more frequently in the PC group in compared to the ASY group. However, without statistical significance. For the -174 G/C SNP in the IL-6 gene, a higher frequency of the G/C heterozygote was observed in the NC group in relation to the PC, as well as the C mutant allele was more frequent in the NC group in relation to the PC and in the NC group compared to ASY. However, with no statistical significance. On the other hand, statistically significant differences (p &lt; 0.05) were observed between the allele frequencies obtained for the variants analyzed in this study in relation to the distributions found in the genomic association studies for other populations
Tipo: Dissertação</description>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/82432">
    <title>Avaliaçãoin vitro da atividade antimicrobiana de biosurfactante complexado com arginina frente a Staphylococcus aureus resistente à meticilina (SARM) e Candida spp. e seu potencial para desagregação de biofilmes em cateteres venosos periférico</title>
    <link>http://repositorio.ufc.br/handle/riufc/82432</link>
    <description>Título: Avaliaçãoin vitro da atividade antimicrobiana de biosurfactante complexado com arginina frente a Staphylococcus aureus resistente à meticilina (SARM) e Candida spp. e seu potencial para desagregação de biofilmes em cateteres venosos periférico
Autor(es): Barroso, Fatima Daiana Dias
Abstract: The spectrum of microbial resistance has been expanding globally, challenging theeffectiveness of antimicrobial therapies and representing a serious threat to public health. Thisissue is further exacerbated by the increasing incidence of biofilm-associated infections.Medical devices, which are widely used in various procedures and treatments, provide afavorable environment for biofilm formation, particularly in catheters, prostheses, and implants.The aim of this study was to evaluate the antimicrobial efficacy of a rhamnolipid complexedwith the amino acid arginine (RLMIX_Arg) against planktonic cells, methicillin-resistantStaphylococcus aureus (MRSA) biofilms, and polymicrobial biofilms formed by MRSA andfluconazole-resistant Candida albicans on polystyrene plates and peripheral venous catheters(PVCs). Additionally, the study assessed the interference of RLMIX_Arg, both in its isolatedform and formulated in a gel, with the biofilm formation process in impregnated catheters.Theminimum inhibitory concentration (MIC) was determined in accordance with CLSI documentsM07-A10 and M23-A3. The assessment of thepharmacological interaction was alsodetermined using the checkerboard methodology. Biofilm formation was assessed throughMTT reduction assays, crystal violet staining, and scanning electron microscopy (SEM).Biofilm formation on catheters was analyzed by counting colony-forming units (CFU/mL).Furthermore, flow cytometry assays were performed to evaluate cell viability and DNAfragmentation in bacterial cells. The MIC of the compound against planktonic MRSA cellsranged from 4 to 16 μg/mL, demonstrating bactericidal activity. Notably, synergy with oxacillinwas observed in 37.5% of the strains, resulting in up to a threefold reduction in oxacillin MIC.For Candida strains, MICs rangedfrom 2 to 13 μg/mL. In addition, concentrations of 64 μg/mLand 80 μg/mL led to asignificant (90%) reduction in biofilm cell viability on polystyrene platesand PVCs, both during the initial formation stage and in mature MRSA biofilms. Forpolymicrobial biofilms formed by MRSA and C. albicans, a concentration of 112 μg/mL(16×MIC) reduced cell viability by approximately 81.8% on plates. Catheters impregnated with&#xD;
RLMIX_Arg at a concentration of 4 mg/mL alone were able to reduce MRSA cell adhesion by29.5%. Prevention of mixed biofilm formation was observed in PVCs impregnated with 10&#xD;
mg/mL of RLMIX_Arg alone, with approximately 93.8% reduction in cell adhesion. The&#xD;
formulation containing 0.9 μg/mL RLMIX_Arg incorporated into Pluronic F-127 gel provedtobe more effective in preventing mixed biofilms on PVCs, reducing adhesion by about99.1%.Impregnated catheters maintained their antimicrobial effect after 28 days of storage. Themechanism of action against planktonic cells possibly involves membrane damage and&#xD;
concentration-dependent DNA fragmentation. These effects were more pronounced when the&#xD;
compound was combined with oxacillin. The findings indicate that RLMIX_Arg shows&#xD;
potential for application in the prevention of infections associated with MRSA biofilms, both&#xD;
isolated and in combination with C. albicans.
Tipo: Tese</description>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repositorio.ufc.br/handle/riufc/78414">
    <title>Perfil clínico-epidemiológico e bacteriológico de otite externa em cães e avaliação da aplicação de prometazina como estratégia antibiofilme</title>
    <link>http://repositorio.ufc.br/handle/riufc/78414</link>
    <description>Título: Perfil clínico-epidemiológico e bacteriológico de otite externa em cães e avaliação da aplicação de prometazina como estratégia antibiofilme
Autor(es): Guedes, Rodrigo Fonseca de Medeiros
Abstract: Otitis externa (OE) is an inflammation of the external ear canal with a complex and&#xD;
multifactorial etiology associated with predisposing, primary and perpetuating factors&#xD;
and secondary bacterial and fungal infections, which lead to recurrence of the disease.&#xD;
However, the treatment of otitis is challenging when analyzing the emergence of&#xD;
biofilm formation associated bacterial infections, a community of sessile bacteria&#xD;
immersed in a polymeric matrix with expression of efflux pumps. Considering the&#xD;
clinical, epidemiological and microbiological profile of otitis, the use of drugs that act&#xD;
on efflux pumps and biofilm is an alternative for the treatment of OE with recurrent&#xD;
bacterial infection. In this context, promethazine (PMZ) is a phenothiazine with&#xD;
reported antimicrobial and antibiofilm activity, as well as being an efflux pump&#xD;
inhibitor. Therefore, the aims of this study were to carry out a clinical-epidemiological&#xD;
and microbiological profile of dogs with recurrent OE and to evaluate the antimicrobial&#xD;
and antibiofilm activity of the topical antimicrobials gentamicin (GEN) and&#xD;
enrofloxacin (ENR), commercial otologic formulations (FO) containing gentamicin (FO&#xD;
GEN) or enrofloxacin (FO ENR), and PMZ against bacterial isolates obtained from&#xD;
dogs with OE, as well as the effect of PMZ on the dynamics of biofilm formation over&#xD;
120 hours, as a proposal for long-term therapy. Therefore, 120 ears of 70 dogs with&#xD;
recurrent OE (50 bilateral and 20 unilateral otitis) were evaluated for the type of otitis&#xD;
(erythematous-ceruminous or suppurative), clinical parameters (erythema, hyperplasia,&#xD;
erosion/ulceration and exudate) and cytological parameters (cocci, bacilli, yeasts and&#xD;
neutrophils) by scores (0 to 4), bacterial isolation profile and antimicrobial sensitivity.&#xD;
The planktonic bacterial sensitivity to PMZ (12.2-6250 µg/mL), GEN (0.125-64&#xD;
µg/mL), ENR, FO GEN and FO ENR (0.03-16 µg/mL) was evaluated to determine the&#xD;
minimum inhibitory concentrations (MIC), following the CLSI recommendations. The&#xD;
minimum biofilm eradication concentration (MBEC) was also determined by broth&#xD;
microdilution. To assess the effect on biofilm growth, PMZ was tested at three&#xD;
concentrations: MIC, MIC/2 and MIC/8, with daily readings at intervals of 48, 72, 96&#xD;
and 120 hours. 174 bacteria were isolated, the most prevalent being Staphylococcus&#xD;
intermedius, Staphylococcus schleiferi, Proteus mirabilis and Pseudomonas aeruginosa,&#xD;
associated with varying clinical and cytological scores and antimicrobial sensitivity&#xD;
profiles. The MICs of PMZ and GEN, ENR and FO ranged from 48.83 to 781.25 µg/mL&#xD;
and 0.0625 to 64 µg/mL, respectively. The MICs of GEN, ENR and FO ranged from 1&#xD;
to 256 µg/mL. PMZ significantly reduced (P&lt;0.05) the biomass of mature biofilm, with&#xD;
BMSCs ranging from 48.8 to 6,250 µg/mL and reduced (P&lt;0.01) biofilm formation for&#xD;
up to 120 hours, at concentrations corresponding to the MIC obtained against each&#xD;
isolate. It was concluded that erythematous-ceruminous had a higher clinical occurrence&#xD;
and the highest clinical and cytological scores were observed in suppurative otitis. PMZ&#xD;
was effective against the microorganisms associated with EO. The data suggest that&#xD;
PMZ is a promising antimicrobial and antibiofilm agent for the treatment and&#xD;
prevention of otitis externa with recurrent bacterial infection in dogs.
Tipo: Tese</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

